A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...
GlobalData on MSN
Virta Health reports improved outcomes in pancreatic cancer trial
The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.
A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...
Researchers found that treating precancerous pancreatic lesions with experimental KRAS inhibitors slowed tumor development and improved survival in mice, demonstrating the potential of intercepting ...
Pancreatic cancer is one of the hardest cancers to treat, which makes early detection so crucial, now AI is lending a hand to ...
Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
FREDERICK, Md. ( DC News Now) — For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer. Frederick Health is the first in the U.S. to bring this ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...
The daughters of a couple who both died of pancreatic cancer said their mother and father died within six and three months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results